A new Northwestern Medicine study published in the Proceedings of the National Academy of Sciences has explored the impacts ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...
Scientists have uncovered the gene-regulation mechanism that determines whether a cell survives or dies when under stress.
Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize ...
University of Arkansas scientists study soybean cyst nematode proteins to develop gene-edited soybean varieties resistant to ...
Morning Overview on MSN
Even a single daily drink raised the risk of cancer and heart disease, a major review found
People who drink as little as one alcoholic beverage per day face measurably higher odds of developing several cancers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results